Brisbane, Australia-Failure of midurethral sling surgery isoften blamed on poor surgical technique, inappropriate indicationsfor surgery, or the sling material itself, according to CindyAmundsen, MD, associate professor of urogynecology at DukeUniversity Medical Center, Durham, NC. Nevertheless, surgeons cantake a number of steps to avoid failure and minimize complications.
Brisbane, Australia-Female urology is a rapidly changing andwide-ranging specialty that requires special expertise, accordingto George Webster, MD, professor of urology and head of the sectionof reconstructive urology, female urology, and urodynamics at DukeUniversity Medical Center, Durham, NC. Because of the highfrequency of concomitant stress incontinence and pelvic prolapse,surgeons must take an integrated approach to correcting bothconditions.
Brisbane, Australia-The artificial urinary sphincter provides"predictable success" in men who suffer from urinary incontinenceafter radical prostatectomy, according to George Webster, MD,professor of urology and head of the section of reconstructiveurology, female urology, and urodynamics at Duke University MedicalCenter, Durham, NC. Functional problems requiring a secondprocedure are not an uncommon problem with the device, he toldattendees at the Urological Society of Australasia annual meetinghere.
When IIEF-EF scores for group on-demand and rehabilitative therapywere compared, there was no significant difference (p=0.31).
Paris-Although a male condition, premature ejaculation has asignificant impact on women, according to a multinational studyanalyzing the effects of premature ejaculation on women and on menwho suffer from it presented by Italian researchers at the EuropeanAssociation of Urology annual congress here.
Brisbane, Australia-Declines in PSA levels and transrectalultrasound prostate volume appear to be useful when evaluatingendoscopic treatment techniques for BPH that do not retrievetissue, according to New Zealand researchers.
Munich, Germany-The phosphodiesterase type-5 inhibitorvardenafil hydrochloride (Levitra) is a safe and effective optionin the treatment of erectile dysfunction in men being treated withcommon medications for hypertension, researchers report in a recentstudy published in the Journal of Sexual Medicine (2005; 2:856-64).Both hypertension and the drugs used to treat it have been known toadversely affect erectile function.
The major discussions of advances in understanding and treating BPHmay take place in the hallways rather than in the official meetingrooms during this month's AUA annual meeting, Claus G. Roehrborn,MD, professor and chairman of the department of urology at theUniversity of Texas Southwestern Medical Center, Dallas, toldUrology Times.
It's safe to say that when the sequencing of the human genome wascompleted in April 2003, the diagnosis and treatment of maleinfertility was turned on its ear.
Urologists attending the 2006 AUA annual meeting can look forwardto hearing about promising new reconstructive techniques for malegenital disorders. Studies will spotlight a number of approachesthat are at various stages of maturity, including some that arebeing reported for the very first time.
Advances in stem cell therapy trials and minimally invasivesurgical procedures are key trends in urinary incontinence that arelikely to emerge at this month's AUA annual meeting. In both humanand animal trials, skeletal muscle cells show significant promiseas an eventual replacement for surgery in treating stressincontinence, said Shlomo Raz, MD, director of female urology,urodynamics, and reconstructive surgery at the UCLA Medical Center.
We are gathering valuable information about the roles of geneticsand diet.
Urologists should begin to assess whether ablative techniques forsmall renal tumors are feasible within their own practiceenvironment.
Attendees at the AUA annual meeting will hear about a number ofexciting developments relating to the treatment of male sexualdysfunction and will learn about important epidemiologic researchthat could have significant implications for clinical management,according to Gregory A. Broderick, MD, professor of urology, MayoClinic, Jacksonville, FL.
Slow, steady, and encouraging are the most appropriate terms todescribe recent changes in the treatment of renal cell carcinoma.Breakthroughs are on the horizon, and two new drugs andevolutionary advances in surgical technique add up to a hopefulpicture.
Pediatric urologists trained solely in traditional surgical methodswould be well advised to use their CME credits for courses inlaparoscopic and robotic surgery techniques. That, says Howard M.Snyder, III, MD, is inevitably the direction in which thesubspecialty is headed.
At the upcoming AUA annual meeting, urologists will see newconcepts emerging from research in both urinary tract infection andprostatitis, but those will take some time to produce newtherapies, cautioned Anthony J. Schaeffer, MD.
The definition of advanced prostate cancer has evolved over thepast decade, and clinical trials now underway are poised totransform clinical practice, according to Paul F. Schellhammer, MD,professor of urology at Eastern Virginia Medical School and programdirector of the Virginia Prostate Center, Norfolk.
Technology is both a long-term commitment and a long-term solution.
Will physicians be more inclined to use electronic prescribing andelectronic health records if their hospital, group practice, oranother entity provide the necessary computers, software, andtechnical support?
Today, interstitial cystitis is being viewed more as a painsyndrome than as a bladder disease, and that new view is drivingmuch of the research that urologists will hear about at this year'sAUA annual meeting and beyond. It should also inform their approachto treatment until the cause and cure are discovered, according toPhilip M. Hanno, MD.
Paris-For most men who have urinary incontinence afterradical prostatectomy, a sling and an artificial urinary sphincter(AUS) offer equally good outcomes, according to findings from aretrospective, double-cohort study reported at the EuropeanAssociation of Urology annual congress here.
Research presented at the upcoming AUA annual meeting will includesome intriguing new findings about the cause, diagnosis, andmanagement of localized prostate cancer, said Richard D. Williams,MD.
This is a sample for your approval of what a page will look likewith your banner ad. Your ad will appear exclusively on allarticles that discuss ED. Your ad will rotate on all general newsarticles. Please submit up to 150 words for inclusion in our about oursponsors section.
This is a sample of how your ads will appear around selected BPHcontent. Your ads will be the exclusive content on BPH articles andwill rotate with the other sponsors on General News items.
The Infusion Nurses Society (INS) has issued revised standards oncatheter stabilization that now recommend the use of a manufacturedcatheter device, when feasible.
Teva Pharmaceutical Industries, Ltd., has been granted FDA approvalfor a generic formulation of mitoxantrone hydrochloride injection,2 mg/mL.
Urologix, Inc., has received FDA approval to market its CoolWavecontrol unit for use with its catheter-based treatments that usemicrowave technology to treat BPH.
According to a recent report from the American Cancer Society,tobacco use, physical inactivity, obesity, and poor nutritionremain major preventable causes of cancer and other diseases in theUnited States.
Primary androgen deprivation therapy appears to control localizedprostate cancer in the majority of patients who receive it, atleast for an intermediate period, according to a study published inCancer (2006; 106:1708-14).